PlumX Metrics
Embed PlumX Metrics

F-Fluciclovine PET Detected Early Tumor Recurrence in Prostatectomy Bed with Low PSA of 0.3 ng/mL but Negative on F-PSMA PET Scan

Clinical Nuclear Medicine, ISSN: 1536-0229, Vol: 48, Issue: 1, Page: 69-70
2023
  • 2
    Citations
  • 0
    Usage
  • 2
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Findings on Prostatectomy Discussed by Investigators at University of Texas MD Anderson Cancer Center (F-18-fluciclovine Pet Detected Early Tumor Recurrence In Prostatectomy Bed With Low Psa of 0.3 Ng/ml but Negative On F-18-psma Pet Scan)

2023 FEB 03 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Medical Devices Daily -- Data detailed on Surgery - Prostatectomy have been

Article Description

A 58-year-old man with metastatic prostate cancer was treated with prostatectomy, radiation therapy to bone metastasis, and androgen deprivation therapy plus abiraterone. He had posttreatment nadir PSA of 0.1 ng/mL. A follow-up 18F-fluciclovine PET performed with PSA of 0.3 ng/mL showed a focal tracer-avid lesion in the left prostatectomy bed. This lesion was negative on 18F-DCFPyL PET/CT, but with typical MRI features for disease recurrence. Minimal urinary activity of fluciclovine helped detection of local disease recurrence in the prostatectomy bed.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know